Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Hematology Reports|October 5, 2018
Clinical significance of dasatinib-induced pleural effusion in patients with de <i>novo</i> chronic myeloid leukemiaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Oncology Letters|September 21, 2017
Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphomaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2015
[Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder in a Patient with Acute Lymphocytic Leukemia]Yoshiko Azuma, Aya Nakaya, Shinya Fujita, et al.
Sensors (Basel, Switzerland)|April 30, 2021
Radiometric Calibration for a Multispectral Sensor Onboard RISESAT Microsatellite Based on Lunar ObservationsMasataka Imai, Junichi Kurihara, Toru Kouyama, et al.
Leukemia Research Reports|March 27, 2019
Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemiaKazuyoshi Ishii, Aya Nakaya, Shinya Fujita, et al.
Hematology Reports|July 27, 2018
Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemiaMasaaki Hotta, Aya Nakaya, Shinya Fujita, et al.
Leukemia Research Reports|July 13, 2018
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomideTomoki Ito, Aya Nakaya, Shinya Fujita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2016
Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myelomaMaiko Esaki, Kazuyoshi Ishii, Yoshiko Azuma, et al.
Annals of Hematology|December 12, 2024
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord bloodYusuke Kubota, Masatoshi Sakurai, Yasuhito Nannya, et al.
European Journal of Haematology|June 22, 2020
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysisAtsushi Satake, Akiko Konishi, Yoshiko Azuma, et al.
Pageof 9